Full IRB Study Title:
A prospective, open-label, randomized, concurrent active-controlled, longitudinal, multicenter, phase 3 clinical study of the safety and efficacy of MACI in patients aged 10 to 17 years with symptomatic chondral or osteochondral defects of the knee due to osteochondritis dissecans or acute trauma (PEAK Clinical Trial)
If you are interested in this study or have questions about your child's eligibility, please contact:
Melanie Morscher, Study Coordinator, 330-543-8935